Skip to main content
URAT1 inhibitor shows ‘substantial’ uric acid reduction in phase 2 gout trial
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
URAT1 inhibitor shows ‘substantial’ uric acid reduction in phase 2 gout trial
User login
Username
Password
Reset your password
Concept
Lead
score
Gout
1
1
Hyperuricemia
0
0.63
Aminotransferase
0
0.42
Electrocardiogram (ECG)
0
0.36
Adverse Effects
0
0.21
Body Mass Index
0
0.21
Cardiovascular disease
0
0.21
Disease Management
0
0.21
Europe
0
0.21
Hyperlipidemia
0
0.21
Kidney
0
0.21
Prophylaxis
0
0.21
Cardiometabolic Risk Factors
0
0.09
Cardiovascular Risk Management
0
0.09
Electrophysiology
0
0.09
Hypertension
0
0.09
Specialty
Lead
score
Rheumatology
1
1
Family Medicine/Primary Care
0
0.8
Internal Medicine
0
0.9
Edit Tags